Drug Shortage Report for MAR-CIPROFLOXACIN
Report ID | 48100 |
Drug Identification Number | 02379686 |
Brand name | MAR-CIPROFLOXACIN |
Common or Proper name | Mar-Ciprofloxacin |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 Tablet |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-05-02 |
Actual start date | 2018-05-02 |
Estimated end date | 2020-01-03 |
Actual end date | 2020-01-03 |
Shortage status | Resolved |
Updated date | 2020-01-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-01-04 | English | Compare |
v8 | 2020-01-03 | French | Compare |
v7 | 2020-01-03 | English | Compare |
v6 | 2018-07-05 | French | Compare |
v5 | 2018-07-05 | English | Compare |
v4 | 2018-05-03 | English | Compare |
v3 | 2018-05-02 | French | Compare |
v2 | 2018-05-02 | French | Compare |
v1 | 2018-05-02 | English | Compare |
Showing 1 to 9 of 9